Anticorps Monoclonal anti-androgen receptor

androgen receptor Monoclonal Antibody for IF, IHC, WB, ELISA

Hôte / Isotype

Mouse / IgG2a

Réactivité testée

Humain, rat, souris

Applications

WB, IP, IHC, IF, ELISA

Conjugaison

Non conjugué

CloneNo.

1F7C12

N° de cat : 66747-1-Ig

Synonymes

AIS, androgen receptor, AR, DHTR, Dihydrotestosterone receptor, HUMARA, HYSP1, KD, NR3C4, SBMA, SMAX1, TFM



Applications testées

Résultats positifs en WBcellules LNCaP, cellules NCCIT, tissu testiculaire humain
Résultats positifs en IHCtissu de cancer de la prostate humain, tissu testiculaire de rat, tissu testiculaire de souris
il est suggéré de démasquer l'antigène avec un tampon de TE buffer pH 9.0; (*) À défaut, 'le démasquage de l'antigène peut être 'effectué avec un tampon citrate pH 6,0.
Résultats positifs en IFtissu de cancer de la prostate humain, cellules LNCaP

Dilution recommandée

ApplicationDilution
Western Blot (WB)WB : 1:600-1:3000
Immunohistochimie (IHC)IHC : 1:5000-1:20000
Immunofluorescence (IF)IF : 1:200-1:800
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, check data in validation data gallery

Informations sur le produit

66747-1-Ig cible androgen receptor dans les applications de WB, IP, IHC, IF, ELISA et montre une réactivité avec des échantillons Humain, rat, souris

Réactivité Humain, rat, souris
Réactivité citéerat, Humain, souris
Hôte / Isotype Mouse / IgG2a
Clonalité Monoclonal
Type Anticorps
Immunogène androgen receptor Protéine recombinante Ag17291
Nom complet androgen receptor
Masse moléculaire calculée 914 aa, 99 kDa
Poids moléculaire observé 110-120 kDa
Numéro d’acquisition GenBankBC132975
Symbole du gène AR
Identification du gène (NCBI) 367
Conjugaison Non conjugué
Forme Liquide
Méthode de purification Purification par protéine A
Tampon de stockage PBS avec azoture de sodium à 0,02 % et glycérol à 50 % pH 7,3
Conditions de stockageStocker à -20°C. Stable pendant un an après l'expédition. L'aliquotage n'est pas nécessaire pour le stockage à -20oC Les 20ul contiennent 0,1% de BSA.

Informations générales

AR, also named as DHTR and NR3C4, belongs to the nuclear hormone receptor family and NR3 subfamily. AR is a ligand-activated transcription factors that regulate eukaryotic gene expression and affect cellular proliferation and differentiation in target tissues. Transcription factor activity is modulated by bound coactivator and corepressor proteins. AR is activated, but not phosphorylated, by HIPK3. Defects in AR are the cause of androgen insensitivity syndrome (AIS), previously known as testicular feminization syndrome (TFM), which is an X-linked recessive form of pseudohermaphroditism due end-organ resistance to androgen. Defects in AR are the cause of spinal and bulbar muscular atrophy X-linked type 1 (SMAX1) which also known as Kennedy disease. Defects in AR may play a role in metastatic prostate cancer. Defects in AR are the cause of androgen insensitivity syndrome partial (PAIS) which also known as Reifenstein syndrome. AR exists various isoforms with MW 110-120 kDa and 75-80 kDa. (PMID: 19244107 )

Protocole

Product Specific Protocols
WB protocol for androgen receptor antibody 66747-1-IgDownload protocol
IHC protocol for androgen receptor antibody 66747-1-IgDownload protocol
IF protocol for androgen receptor antibody 66747-1-IgDownload protocol
Standard Protocols
Click here to view our Standard Protocols

Publications

SpeciesApplicationTitle
ratIHC

Development

Human prostate organoid generation and the identification of prostate development drivers using inductive rodent tissues

Authors - Parmveer Singh
ratWB

Chin J Nat Med

Eucommia lignans alleviate the progression of diabetic nephropathy through mediating the AR/Nrf2/HO-1/AMPK axis in vivo and in vitro

Authors - Qi Huang
human,mouseWB,IF,IP

iScience

WTAP boosts lipid oxidation and induces diabetic cardiac fibrosis by enhancing AR methylation

Authors - Kai Song
humanWB,IF

Gynecol Endocrinol

N6-methyladenosine demethylase FTO related to hyperandrogenism in PCOS via AKT pathway

Authors - Yuan-Xue Jing